ANTX
AN2 Therapeutics Inc
NASDAQ: ANTX · HEALTHCARE · BIOTECHNOLOGY
$4.68
-1.27% today
Updated 2026-04-29
Market cap
$163.78M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.16
Dividend yield
—
52W range
$1 – $7
Volume
1.7M
AN2 Therapeutics Inc (ANTX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |